| HIV Infection |
1 |
1 |
| Menopause |
0 |
0.99 |
| Cardiovascular disease |
0 |
0.36 |
| Drug Interaction |
0 |
0.36 |
| Estrogen |
0 |
0.36 |
| Amenorrhea |
0 |
0.29 |
| Bone |
0 |
0.29 |
| Hormone Replacement Therapy |
0 |
0.29 |
| Clinical Guidelines |
0 |
0.98 |
| Hormonal Therapy |
0 |
0.22 |
| Quality of Life |
0 |
0.22 |
| AIDS |
0 |
0.14 |
| Hospital |
0 |
0.14 |
| UK Site Content |
0 |
0.14 |
| Activism |
0 |
0.07 |
| Birth |
0 |
0.07 |
| Blood |
0 |
0.07 |
| Board Certification |
0 |
0.07 |
| Body Mass Index |
0 |
0.07 |
| Breast |
0 |
0.07 |
| Canada |
0 |
0.07 |
| Cancer |
0 |
0.07 |
| CD4 |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Cognition |
0 |
0.07 |
| Cognitive Behavioral Therapy |
0 |
0.07 |
| Fellowship |
0 |
0.07 |
| Heart |
0 |
0.07 |
| HIV Diagnosis |
0 |
0.07 |
| Liver |
0 |
0.07 |
| Massachusetts |
0 |
0.07 |
| Match |
0 |
0.07 |
| Metabolism |
0 |
0.07 |
| Neurotransmitters |
0 |
0.07 |
| New York |
0 |
0.07 |
| Night Sweats |
0 |
0.07 |
| Peer Review |
0 |
0.07 |
| Primary Care |
0 |
0.07 |
| Psychotherapy |
0 |
0.07 |
| Psychotropic Drugs |
0 |
0.07 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.07 |
| Breast Cancer |
0 |
0.06 |
| Cardiovascular Risk Management |
0 |
0.05 |
| Medical Life |
0 |
0.01 |